Aster Capital Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.96K Buy
+206
New +$8.12K ﹤0.01% 811
2025
Q4
– Sell
-2,058
Closed -$33.2K – 1253
2025
Q3
$33.2K Buy
+2,058
New +$33.3K 0.02% 582
2025
Q1
– Sell
-190
Closed -$4.71K – 1454
2024
Q4
$4.71K Sell
190
-101
-35% -$2.86K ﹤0.01% 867
2024
Q3
$8.3K Buy
+291
New +$8.58K ﹤0.01% 833

Other funds holding IMVT

Aster Capital Management's IMVT Position: Q3 2026 in Review

Aster Capital Management opened a new position in Immunovant (IMVT) in Q3 2026: 206 shares worth $6.96K. The stake represents ﹤0.01% of the portfolio and ranks #811 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in IMVT as recently as Q3 2025.

Aster Capital Management first reported a position in IMVT in Q3 2024 and has held it in 4 quarters since. The position peaked at $33.2K in Q3 2025. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Aster Capital Management held 206 shares of Immunovant worth $6.96K as of Q3 2026.
  • Immunovant was a new Aster Capital Management position in Q3 2026.
  • Immunovant made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #811 holding.
  • Aster Capital Management first reported a position in Immunovant in Q3 2024 and has held it in 4 quarters since.
  • Aster Capital Management's Immunovant position peaked at $33.2K in Q3 2025.
  • 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.